Home
/
NEPHROS INC
/
Financials
/
Quarterly
NEPHROS INC — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that NEPHROS INC filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$4.76M
Nov 6, 2025
Q2
2025
Jun 30, 2025
$4.42M
Aug 7, 2025
Q1
2025
Mar 31, 2025
$4.88M
May 15, 2025
Q3
2025
Sep 30, 2024
$3.52M
Nov 6, 2025
Q2
2025
Jun 30, 2024
$3.25M
Aug 7, 2025
Q1
2025
Mar 31, 2024
$3.52M
May 15, 2025
Q3
2024
Sep 30, 2023
$3.74M
Nov 14, 2024
Q2
2024
Jun 30, 2023
$3.55M
Aug 8, 2024
Q1
2024
Mar 31, 2023
$3.70M
May 9, 2024
Q3
2023
Sep 30, 2022
$2.41M
Nov 8, 2023
Q2
2023
Jun 30, 2022
$2.85M
Aug 9, 2023
Q1
2023
Mar 31, 2022
$2.16M
May 10, 2023
Q3
2022
Sep 30, 2021
$2.58M
Nov 15, 2022
Q2
2022
Jun 30, 2021
$2.27M
Aug 15, 2022
Q1
2022
Mar 31, 2021
$2.74M
May 5, 2022
Q3
2021
Sep 30, 2020
$2.12M
Nov 4, 2021
Q2
2021
Jun 30, 2020
$1.58M
Aug 5, 2021
Q1
2021
Mar 31, 2020
$2.53M
May 6, 2021
Q3
2020
Sep 30, 2019
$3.10M
Nov 5, 2020
Q2
2020
Jun 30, 2019
$2.31M
Aug 5, 2020
Revenue (Net Sales) — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q1
2018
Mar 31, 2018
$985.0K
May 9, 2018
Q3
2017
Sep 30, 2017
$916.0K
Nov 9, 2017
Q2
2017
Jun 30, 2017
$859.0K
Aug 8, 2017
Q1
2018
Mar 31, 2017
$734.0K
May 9, 2018
Q3
2017
Sep 30, 2016
$475.0K
Nov 9, 2017
Q2
2017
Jun 30, 2016
$509.0K
Aug 8, 2017
Q1
2017
Mar 31, 2016
$590.0K
May 9, 2017
Q3
2016
Sep 30, 2015
$320.0K
Nov 10, 2016
Q2
2016
Jun 30, 2015
$567.0K
Aug 8, 2016
Q1
2016
Mar 31, 2015
$544.0K
May 11, 2016
Q3
2015
Sep 30, 2014
$491.0K
Nov 10, 2015
Q2
2015
Jun 30, 2014
$441.0K
Aug 10, 2015
Q1
2015
Mar 31, 2014
$473.0K
May 15, 2015
Q3
2014
Sep 30, 2013
$418.0K
Nov 13, 2014
Q2
2014
Jun 30, 2013
$575.0K
Aug 14, 2014
Q1
2014
Mar 31, 2013
$521.0K
May 14, 2014
Q3
2013
Sep 30, 2012
$604.0K
Nov 14, 2013
Q2
2013
Jun 30, 2012
$302.0K
Aug 13, 2013
Q1
2013
Mar 31, 2012
$533.0K
May 8, 2013
Q3
2012
Sep 30, 2011
$407.0K
Nov 9, 2012
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$337.0K
Nov 6, 2025
Q2
2025
Jun 30, 2025
$237.0K
Aug 7, 2025
Q3
2025
Jun 30, 2025
$237.0K
Nov 6, 2025
Q1
2025
Mar 31, 2025
$558.0K
May 15, 2025
Q2
2025
Mar 31, 2025
$558.0K
Aug 7, 2025
Q3
2025
Mar 31, 2025
$558.0K
Nov 6, 2025
Q3
2025
Sep 30, 2024
$183.0K
Nov 6, 2025
Q3
2025
Jun 30, 2024
($289.0K)
Nov 6, 2025
Q2
2025
Jun 30, 2024
($289.0K)
Aug 7, 2025
Q2
2025
Mar 31, 2024
($169.0K)
Aug 7, 2025
Q3
2025
Mar 31, 2024
($169.0K)
Nov 6, 2025
Q1
2025
Mar 31, 2024
($169.0K)
May 15, 2025
Q3
2024
Sep 30, 2023
($182.0K)
Nov 14, 2024
Q3
2024
Jun 30, 2023
($433.0K)
Nov 14, 2024
Q2
2024
Jun 30, 2023
($433.0K)
Aug 8, 2024
Q2
2024
Mar 31, 2023
($306.0K)
Aug 8, 2024
Q3
2024
Mar 31, 2023
($306.0K)
Nov 14, 2024
Q1
2024
Mar 31, 2023
($306.0K)
May 9, 2024
Q3
2022
Sep 30, 2022
($3.23M)
Nov 15, 2022
Q2
2022
Jun 30, 2022
($1.14M)
Aug 15, 2022
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$314.0K
Nov 6, 2025
Q2
2025
Jun 30, 2025
$248.0K
Aug 7, 2025
Q1
2025
Mar 31, 2025
$566.0K
May 15, 2025
Q3
2025
Sep 30, 2024
$206.0K
Nov 6, 2025
Q2
2025
Jun 30, 2024
($317.0K)
Aug 7, 2025
Q1
2025
Mar 31, 2024
($200.0K)
May 15, 2025
Q3
2024
Sep 30, 2023
($203.0K)
Nov 14, 2024
Q2
2024
Jun 30, 2023
($435.0K)
Aug 8, 2024
Q1
2024
Mar 31, 2023
($306.0K)
May 9, 2024
Q3
2023
Sep 30, 2022
($1.28M)
Nov 8, 2023
Q2
2023
Jun 30, 2022
($814.0K)
Aug 9, 2023
Q1
2023
Mar 31, 2022
($1.55M)
May 10, 2023
Q3
2022
Sep 30, 2021
($802.0K)
Nov 15, 2022
Q2
2022
Jun 30, 2021
($1.12M)
Aug 15, 2022
Q1
2022
Mar 31, 2021
($1.02M)
May 5, 2022
Q3
2021
Sep 30, 2020
($932.0K)
Nov 4, 2021
Q2
2021
Jun 30, 2020
($1.60M)
Aug 5, 2021
Q1
2021
Mar 31, 2020
($1.03M)
May 6, 2021
Q3
2020
Sep 30, 2019
($695.0K)
Nov 5, 2020
Q2
2020
Jun 30, 2019
($868.0K)
Aug 5, 2020